Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective

Cost Effectiveness and Resource Allocation : C/E
Dhvani ShahA Ismaila

Abstract

Cost-effectiveness of once-daily umeclidinium bromide (UMEC) was compared with once-daily tiotropium (TIO) and once-daily glycopyrronium (GLY) in patients with chronic obstructive pulmonary disease (COPD) from a UK National Health Service (NHS) perspective. A linked-equation model was implemented to estimate COPD progression, associated healthcare costs, exacerbations rates, life years (LY) and quality-adjusted LY (QALYs). Statistical risk equations for endpoints and resource use were derived from the ECLIPSE and TORCH studies, respectively. Treatment effects [mean (standard error)] at 12 weeks on forced expiratory volume in 1 s and St George's Respiratory Questionnaire score were obtained from the intention-to-treat populations of two head-to-head studies [GSK study identifiers 201316 (NCT02207829) and 201315 (NCT02236611)] which compared UMEC 62.5 mcg with TIO 18 mcg and UMEC 62.5 mcg with GLY 50 mcg, respectively. Treatment costs reflect UK list prices (2016) and NHS unit costs; UMEC and GLY prices being equal and less than TIO. A lifetime horizon, discounted costs and effects at 3.5% were used. Sensitivity analyses were performed to evaluate the robustness of variations in input parameters and assumptions in the model. Over...Continue Reading

References

Jan 14, 2004·Chest·Donald P Tashkin, Christopher B Cooper
Feb 23, 2007·The New England Journal of Medicine·Peter M A CalverleyUNKNOWN TORCH investigators
Oct 7, 2008·The New England Journal of Medicine·Donald P TashkinUNKNOWN UPLIFT Study Investigators
Sep 14, 2010·Respiratory Research·Alvar AgustiUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators
Mar 16, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Helen J StarkiePaul Jones
Mar 25, 2011·The New England Journal of Medicine·Claus VogelmeierUNKNOWN POET-COPD Investigators
May 23, 2012·Pharmacological Reviews·Mario CazzolaM Gabriella Matera
Oct 3, 2012·Respiratory Physiology & Neurobiology·Marc DecramerGlenn Crater
Aug 21, 2013·The European Respiratory Journal·Roopa TrivediAlison Church
Aug 17, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Martine HoogendoornMaureen P M H Rutten-van Mölken
Oct 15, 2014·Expert Review of Respiratory Medicine·Andrea SegretiMario Cazzola
Jun 2, 2015·European Respiratory Review : an Official Journal of the European Respiratory Society·Bartolome R CelliUNKNOWN ATS/ERS Task Force for COPD Research
Aug 20, 2015·Cost Effectiveness and Resource Allocation : C/E·Oskar EklundFredrik Borgström
Sep 2, 2015·Applied Health Economics and Health Policy·Madlaina Costa-ScharplatzDavid Price
Oct 10, 2015·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Alex ExuzidesSebastian Gonzalez-McQuire
Oct 24, 2015·Respirology : Official Journal of the Asian Pacific Society of Respirology·José Luis López-CamposJoan B Soriano
Dec 22, 2015·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S Ehteshami-AfsharM Sadatsafavi
Feb 6, 2016·International Journal of Chronic Obstructive Pulmonary Disease·Marc MiravitllesFrancisco Garcia-Rio
Apr 23, 2016·International Journal of Chronic Obstructive Pulmonary Disease·Gregory FeldmanRoopa Trivedi
Nov 1, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·N A RisebroughA Ismaila
Jun 19, 2016·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Andrew H BriggsDavid A Lomas
Aug 4, 2016·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Maggie TabbererDavid A Lomas
Mar 16, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Martine HoogendoornMaureen P M H Rutten-van Mölken
Apr 1, 2017·International Journal of Chronic Obstructive Pulmonary Disease·Gustavo J RodrigoKonstantinos Kostikas

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02207829
NCT02236611

Software Mentioned

GALAXY

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.